Literature DB >> 6503620

The effect of neurotensin on the concentration of cholesterol and bile acids in the guinea pig.

L Peric-Golia, C F Gardner, D E Wilson, M Peric-Golia.   

Abstract

In guinea pigs, total plasma cholesterol concentrations increased above the control values after single intravenous injections and after 3 days of continuous subcutaneous administration of neurotensin (NT). A high dose of NT (125 pmol/100 g body weight) induced tachycardia and severe respiratory distress; the lowest dose (1.25 pmol/100 g body weight) had the greatest hypercholesterolemic effect 15 min after the injections. The bulk of the total plasma cholesterol was in low density lipoprotein fractions. Cholesterol increased in the same fractions after intravenous administrations of NT. NT induced a decrease in the cholesterol content in the ileum but did not affect significantly the cholesterol content in the liver, kidneys or adrenals. In 48-hr fasted controls, plasma cholesterol concentration and cholesterol content in the liver, kidneys, adrenals and terminal ileum increased; after intravenous injections of NT, plasma cholesterol concentration further increased but cholesterol content of the liver, kidneys and ileum decreased. In fed animals, the concentration of the biliary taurochenodeoxycholic acid increased above the control values 5 and 35 min after the intravenous injections of NT. In fasted controls, the total concentration of bile acids was higher than in fed controls, but only the concentration of taurochenodeoxycholic acid further increased after the injections of NT. Proportionately more taurochenodeoxycholic acid than cholesterol was present in bile after the intravenous injections of NT. These data are consistent with the hypothesis that NT has a regulatory role in intestinal cholesterol transport.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6503620     DOI: 10.1007/bf02534468

Source DB:  PubMed          Journal:  Lipids        ISSN: 0024-4201            Impact factor:   1.880


  20 in total

1.  Colorimetry of serum cholesterol with use of ferric acetate/uranyl acetate and ferrous sulfate/sulfuric acid reagents.

Authors:  D H Jung; H G Biggs; W R Moorehead
Journal:  Clin Chem       Date:  1975-09       Impact factor: 8.327

2.  Ultraviolet spectrophotometric method for the determination of cholesterol.

Authors:  B I WEIGENSBERG; G C McMILLAN
Journal:  Am J Clin Pathol       Date:  1959-01       Impact factor: 2.493

Review 3.  Neurotensin, a biologically active peptide.

Authors:  G Bissette; P Manberg; C B Nemeroff; A J Prange
Journal:  Life Sci       Date:  1978-11-27       Impact factor: 5.037

4.  Hyperglycemic effect of neurotensin, a hypothalamic peptide.

Authors:  R E Carraway; L M Demers; S E Leeman
Journal:  Endocrinology       Date:  1976-12       Impact factor: 4.736

5.  The effect of some brain/gut peptides on plasma cholesterol levels in the rat.

Authors:  L Peric-Golia; C F Gardner; M Peric-Golia
Journal:  Peptides       Date:  1980       Impact factor: 3.750

6.  Substance P and neurotensin: opposite effects on plasma cholesterol levels in ovariectomized conscious rats.

Authors:  E Vijayan; K Raju
Journal:  Experientia       Date:  1982-07-15

Review 7.  Intestinal lipoprotein metabolism.

Authors:  P H Green; R M Glickman
Journal:  J Lipid Res       Date:  1981-11       Impact factor: 5.922

8.  Gastrointestinal neurotensin-like immunoreactivity (NTLI) in lean and obese Zucker rats.

Authors:  J L Miller; M S Hendricks
Journal:  Horm Metab Res       Date:  1981-09       Impact factor: 2.936

9.  Neurotensin and substance P: differential effects on plasma cholesterol levels in conscious ovariectomized rats.

Authors:  K Raju; E Vijayan
Journal:  Regul Pept       Date:  1981-08

10.  Substance P and neurotensin: discovery, isolation, chemical characterization and physiological studies.

Authors:  S E Leeman
Journal:  J Exp Biol       Date:  1980-12       Impact factor: 3.312

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.